• Skip to primary navigation
  • Skip to main content
  • Skip to footer
ElevateBio

ElevateBio

Powering the creation of cell & gene therapies at a speed the world deserves.

  • Investors & Media
    • Investors & Media Overview
    • Press Releases
    • Posters & Publications
    • Elevated Insights
    • Whitepapers
  • Careers
  • Locations
  • Contact
  • Search
  • Manufacturing & Development Services
    • End-to-End Capabilities Overview
    • cGMP Manufacturing and Automation
    • Process Development
    • Analytical Development
    • Next-Generation Sequencing
    • Quality
    • Regulatory CMC
    • ElevateBio BaseCamp Certifications and Compliance
    • Modalities Powered by ElevateBio
  • Gene Editing Technologies and R&D
    • Technology Platforms Overview
    • Technology Platform
    • Therapeutic Applications
    • AI & Protein Engineering
  • Genetic Medicines
  • Partnering
  • About
    • About Overview
    • How We Work
    • Our Team
    • Culture of Expedition
    • Careers
  • Investors & Media
    • Investors & Media Overview
    • Press Releases
    • Posters & Publications
    • Elevated Insights
    • Whitepapers
  • Careers
  • Locations
  • Contact
  • Manufacturing & Development Services basecamp

    Basecamp
    Manufacturing & Development Services Overview

    Capabilities & Services
    • cGMP Manufacturing and Automation
    • Process Development
    • Analytical Development
    • Next-Generation Sequencing
    Expertise
    • Quality
    • Regulatory CMC
    • BaseCamp Certifications and Compliance
    • Modalities Powered by ElevateBio
  • Gene Editing Technologies and R&D life edit

    Life Edit
    Gene Editing Technologies and R&D Overview

    • Technology Platform
    • Therapeutic Applications
    • AI & Protein Engineering
  • Genetic Medicines
  • Partnering
  • About
    • About Overview
    • How We Work
    • Our Team
    • Culture of Expedition
    • Careers
Home / Investors & Media / Posters & Presentations / Engineering potency and specificity of base editors towards genomic medicine

// January 22, 2026 | 7th International Conference on Base Editing, Prime Editing & Related Enzymes (Deaminet 2026)

Engineering potency and specificity of base editors towards genomic medicine

Ron Chong

Vice President, Technology

This presentation focuses on how ElevateBio Life Edit leveraged our large collection of base editors to enable precise correction of disease-causing mutations, as well as how we developed an engineering framework that delivers the specificity and potency required to meet the rigorous criteria for pre-clinical therapeutic candidate development.

Footer

ElevateBio

Investors & Media

LinkedIn Twitter

© 2025 ElevateBio. All Rights Reserved.

Privacy & Cookie Policy

  • Manufacturing & Development Services basecamp
  • Gene Editing Technologies and R&D life edit
  • Genetic Medicines
  • Partnering
  • About
  • Posters & Publications
  • Elevated Insights
  • Careers
  • Locations
  • Contact
MENU
  • Manufacturing & Development Services
    • End-to-End Capabilities Overview
    • cGMP Manufacturing and Automation
    • Process Development
    • Analytical Development
    • Next-Generation Sequencing
    • Quality
    • Regulatory CMC
    • ElevateBio BaseCamp Certifications and Compliance
    • Modalities Powered by ElevateBio
  • Gene Editing Technologies and R&D
    • Technology Platforms Overview
    • Technology Platform
    • Therapeutic Applications
    • AI & Protein Engineering
  • Genetic Medicines
  • Partnering
  • About
    • About Overview
    • How We Work
    • Our Team
    • Culture of Expedition
    • Careers
  • Investors & Media
    • Investors & Media Overview
    • Press Releases
    • Posters & Publications
    • Elevated Insights
    • Whitepapers
  • Careers
  • Locations
  • Contact